Stablecoin Development Financial Statements
NYSE: SDEVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.50-0.0574 (-10.30%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Stablecoin Development revenue and earnings
Stablecoin Development reported a net loss of $630.8 million, compared with a loss of $7.2 million a year earlier.
Summary generated from market data by MetaCap's automated system. Methodology
Stablecoin Development income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 9.78M | 10.46M | 14.40M | 10.20M | 9.93M | 6.60M | 12.51M | 18.23M | 11.90M |
| Revenue growth (YoY) | — | -6.45% | -27.42% | +41.16% | +2.72% | +50.54% | -47.24% | -31.39% | +53.23% | +171.56% |
| Cost of Revenue | — | 3.30M | 4.37M | 6.62M | 3.69M | 3.97M | 1.74M | 1.50M | 2.78M | 2.46M |
| Gross Profit | — | 6.48M | 6.08M | 7.78M | 6.51M | 5.96M | 4.86M | 11.01M | 15.45M | 9.43M |
| Operating Expenses | 8.44M | 7.38M | 10.19M | 22.20M | 15.38M | 12.39M | 14.26M | 18.88M | 22.76M | 20.41M |
| Research & Development | — | 42.00K | 34.00K | 174.00K | 44.00K | 285.00K | 184.00K | 259.00K | 410.00K | 1.37M |
| Selling, General & Admin | — | 11.41M | 10.15M | 15.29M | 15.33M | 12.11M | 14.08M | 18.62M | 22.35M | 19.04M |
| Operating Income | -8.44M | -7.38M | -4.10M | -14.42M | -8.86M | -6.43M | -9.40M | -7.87M | -7.31M | -10.98M |
| Other Income (Expense) | -20.00K | -581.00K | -369.00K | -276.00K | -1.58M | 605.00K | -1.43M | 19.00K | 12.00K | -68.00K |
| Pretax Income | -641.86M | -8.75M | -9.64M | -10.61M | -5.82M | -11.03M | -9.65M | -6.54M | -7.40M | -13.15M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 5.00K | 6.00K | 4.00K | 3.00K | 2.00K |
| Net Income | -630.78M | -7.22M | -9.64M | -10.61M | -5.82M | -11.04M | -9.66M | -6.54M | -7.40M | -13.15M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -108.39 | -12.68 | -139.14 | -10.10 | -5.26 | -0.31 | -0.48 | -0.39 | -0.48 | -1.40 |
| EPS (Diluted) | — | — | — | — | -150.00 | -0.31 | -0.48 | -0.46 | -0.48 | -1.40 |
| Shares Outstanding (Basic) | 5.82M | 679.00K | 120.00K | 1.61M | 1.25M | 35.08M | 21.64M | 16.92M | 15.32M | 9.41M |
| Shares Outstanding (Diluted) | — | — | — | — | 43.66M | 35.08M | 21.64M | 17.06M | 15.32M | 9.41M |
| EBITDA | — | -7.34M | -4.05M | -14.30M | -8.80M | -6.38M | -9.34M | -7.61M | -7.22M | -10.87M |
| Gross Margin | — | 66.26% | 58.19% | 54.02% | 63.85% | 60.04% | 73.66% | 87.98% | 84.73% | 79.29% |
| Operating Margin | — | -75.44% | -39.23% | -100.09% | -86.85% | -64.69% | -142.45% | -62.93% | -40.10% | -92.31% |
| Net Margin | — | -73.85% | -92.20% | -73.65% | -57.08% | -111.12% | -146.36% | -52.33% | -40.61% | -110.54% |
This table shows 10 annual periods of Stablecoin Development's income statement, from FY 2025 back to FY 2016, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow SDEV's reporting calendar. What is a income statement?